
As Medical Manager, Consumer & Partnerships, you will shape how Medical engages with people living with obesity as they find information and care through new channels. You will turn consumer insight and scientific evidence into medical strategy, partnerships and initiatives that improve obesity care in Belgium and Luxembourg. Your work will create value for patients, healthcare professionals and the healthcare system, and help Medical keep pace as models of care change.
You will lead the medical approach to consumer engagement and emerging healthcare channels, with a primary focus on obesity and links to diabetes and related cardiometabolic priorities where relevant.
You will join the Medical Affairs team in Product & Portfolio Strategy, where colleagues connect commercial strategy, medical affairs and business development to help guide the portfolio and strengthen competitiveness. You will cover Belgium and Luxembourg and link local opportunities to EUCAN and BA West.
Your closest partners will be colleagues in Business Development, Commercial, Market Access/Public Affairs, Regulatory, Safety and Legal. You will bring the medical perspective into these discussions, help set clear governance for partnerships and influence without formal authority. Externally, you will work with physicians, Digital Opinion Leaders, digital health entrepreneurs, private clinics and healthcare providers.
The position is office based, with regular field presence, time with external stakeholders and attendance at international conferences and meetings.
You will work in an area where Novo does not yet have a fully established way of working, so your ideas will shape how Medical engages beyond traditional scientific channels. You will build new skills through close work across Medical, Business Development, Commercial and other functions, and be trusted to take ownership and make your voice heard.
You will be supported to perform at your best, with clear expectations and honest feedback, as we move with clarity and speed towards progress for people living with obesity.
Salary: For this role, the Annual Base Salary ranges from Euro 88,690 – 133,040 corresponding to the level of the position. The placement within the salary range will be assessed during the recruitment process based on the candidate’s skills, competencies, knowledge and relevant experience.
Your impact begins today. If you are ready to turn consumer insight and scientific evidence into partnerships that improve obesity care.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html